Potential Therapeutic Approach of Intravenous Immunoglobulin Against Covid-19

Potential Therapeutic Approach of Intravenous Immunoglobulin Against Covid-19 Publisher

Kolahchi Z¹ ; Sohrabi H¹ ; Ekrami Nasab S¹ ; Jelodari Mamaghani H¹ ; Keyfari Alamdari M¹ ; Rezaei N^{2, 3, 4}

Source: Allergy# Asthma and Clinical Immunology Published:2021

Abstract

Since the outbreak of the novel coronavirus disease (COVID-19), the therapeutic and management options to reduce the burden of the COVID-19 disease are under investigation. IVIG therapy is used as an effective treatment for immunodeficient patients and patients with inflammatory or autoimmune conditions. The therapeutic effect of IVIG in COVID-19 patients has been investigated. But, the results are controversial and some studies reported no benefit of IVIG therapy. More clinical trials on the effect of IVIG therapy in COVID-19 patients should be performed to establish a certain conclusion about IVIG effectiveness. © 2021, The Author(s).

Related Docs

View other Related Docs

1. Recent Advances in Antibody-Based Immunotherapy Strategies for Covid-19, Journal of Cellular Biochemistry (2021)

2. Immune-Based Therapeutic Approaches in Covid-19, Biomedicine and Pharmacotherapy (2022)

3. The Immune System As a Target for Therapy of Sars-Cov-2: A Systematic Review of the Current Immunotherapies for Covid-19, Life Sciences (2020)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (13)

Fereshte Ghiasvand (1)

Style	Citing Format
MLA	Kolahchi Z, et al.. "Potential Therapeutic Approach of Intravenous Immunoglobulin Against Covid-19." Allergy# Asthma and Clinical Immunology, vol. 17, no. 1, 2021, pp. -.
APA	Kolahchi Z, Sohrabi H, Ekrami Nasab S, Jelodari Mamaghani H, Keyfari Alamdari M, Rezaei N (2021). Potential Therapeutic Approach of Intravenous Immunoglobulin Against Covid-19. Allergy# Asthma and Clinical Immunology, 17(1), -.
Chicago	Kolahchi Z, Sohrabi H, Ekrami Nasab S, Jelodari Mamaghani H, Keyfari Alamdari M, Rezaei N. "Potential Therapeutic Approach of Intravenous Immunoglobulin Against Covid-19." Allergy# Asthma and Clinical Immunology 17, no. 1 (2021): -.
Harvard	Kolahchi Z et al. (2021) 'Potential Therapeutic Approach of Intravenous Immunoglobulin Against Covid-19', Allergy# Asthma and Clinical Immunology, 17(1), pp. -.
Vancouver	Kolahchi Z, Sohrabi H, Ekrami Nasab S, Jelodari Mamaghani H, Keyfari Alamdari M, Rezaei N. Potential Therapeutic Approach of Intravenous Immunoglobulin Against Covid-19. Allergy# Asthma and Clinical Immunology. 2021;17(1):-.
BibTex	@article{ author = {Kolahchi Z and Sohrabi H and Ekrami Nasab S and Jelodari Mamaghani H and Keyfari Alamdari M and Rezaei N}, title = {Potential Therapeutic Approach of Intravenous Immunoglobulin Against Covid-19}, journal = {Allergy# Asthma and Clinical Immunology}, volume = {17}, number = {1}, pages = {-}, year = {2021} }
RIS	TY - JOUR AU - Kolahchi Z AU - Sohrabi H AU - Ekrami Nasab S AU - Jelodari Mamaghani H AU - Keyfari Alamdari M AU - Rezaei N TI - Potential Therapeutic Approach of Intravenous Immunoglobulin Against Covid-19 JO - Allergy# Asthma and Clinical Immunology VL - 17 IS - 1 SP - EP - PY - 2021 ER -

Science Communicator Platform

Authors

Abstract